Vivan Life Sciences Private Limited - Due diligence report

A 360° intelligence report on Vivan Life Sciences Private Limited: trust score, financial health, credit view, compliance, directors, growth…

2010-04-28 Thane, Maharashtra Active Unlisted Active Compliant
Share
VL Vivan Life Sciences Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Vivan Life Sciences Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
76/100
Trust Score
Low Risk

Vivan Life Sciences Private Limited is assessed as Low Risk with a Trust Score of 76/100. Vivan Life Sciences Private Limited is an active private limited indian non-government company incorporated in 2010, operating in the Life Sciences sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 18 Jul 2026 from the latest processed filings. Vivan Life Sciences Private Limited snapshot & full profile →

Financial Health › Neutral
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
76/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
50/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
80/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
45/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
50/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 80/100 Low Risk
  • Liabilities ≈ 38% EBITDA - serviceable.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Moderate gearing (D/E 1.42).
  • Working-capital cover adequate.
  • Externally credit-rated (SME).

Charges position: 5 open (11.00 cr) · 3 satisfied (3.46 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Others3 48.0 cr
Axis Bank Limited1 48.0 cr
Standard Chartered Bank2 48.0 cr
Icici Bank Limited1 48.0 cr
State Bank Of India1 48.0 cr
Compliance Score: 88/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
  • 2 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
MANOHAR VISHWANATHAM BOMMANPAD 01234567 Director 01/04/2018 6 yrs Approved
SATISH RAMSHANKAR VARMA 01234567 Director 01/04/2018 6 yrs Approved
SHAILAJA BOMMANPAD MANOHAR 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
1
Group entities
1
Capital events
3 allotment(s) · 2 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Shcova Laboratories Private Limited Subsidiary Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 45 · Distress 50
Growth signals & trust indicators
Asset base grew 2.1x - capacity expansion.
Operating for 16+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
Outside liabilities up 24% in a year.
5 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence73/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 3 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment73/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 5 open charge(s) of 11.00 cr already registered.
  • Compliance record supports lending.
Investor view54/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2024
Last AGM held
Annual general meeting
15 May 2024
Charge created
Others - 3.50 cr
Charge created
Others - 1.00 cr
31 Mar 2024
Latest balance sheet
Filed with ROC
26 Oct 2023
Charge created
Standard Chartered Bank - 1.50 cr
29 Apr 2022
Charge created
Others - 1.50 cr
31 Mar 2021
Share transfer (FY 2021)
109200.00000000 shares to SHAILAJA BOMMANPAD
16 Feb 2020
Securities allotted
910000 Equity Shares - 91.00 Lakh raised
16 Feb 2019
Securities allotted
910000 Equity Shares - 91.00 Lakh raised
09 May 2018
Charge satisfied
Standard Chartered Bank
30 Jan 2018
Charge created
Axis Bank Limited - 3.50 cr
20 Mar 2017
Charge satisfied
State Bank Of India
09 May 2016
Director appointed
MANOHAR VISHWANATHAM BOMMANPAD (Director)
31 Mar 2016
Share transfer (FY 2016)
72800.00000000 shares to MANOHAR SHAILAJA
Charge satisfied
Icici Bank Limited
10

Key Observations

Auto-generated from the data above
Revenue declined 0.86 over the last 4 financial year(s).
Net profit margin moved from 61% to 38%.
Debt-to-equity stands at 1.42 - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
2 active GST registration(s) indicate ongoing business operations.
Operates a group structure with 1 subsidiary(ies) - assess on a consolidated basis.
Carries an external credit rating of SME from Crisil.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 3 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Meganova Constructions Private Limited U70109WB2021PTC247192 Dagapur, West Bengal, India
Madhav Sales Corporation Private Limited U24110MP2018PTC045654 Indore, Madhya Pradesh, India
Sharda Metals Private Limited U27200MH1973PTC016966 W.E.F. 01.05.1998., Maharashtra, India
Talianna Consultants Private Limited U74140DL2006PTC147383 New Delhi, Delhi, India
Radiance Chemsol Private Limited U51101MH2011PTC221079 Mumbai, Maharashtra, India
Ig Ispat India Private Limited U27205KA2022PTC158277 Chikkabalapur, Karnataka, India
Ssv Growell Hatcheries India Private Limited U74900KA2010PTC053265 Bidar, Karnataka, India
Shib Charan Dass Industries Private Limited U24100HR1991PTC031361 Haryana, Haryana, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Vivan Life Sciences Private Limited before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Vivan Life Sciences Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 80/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 45/100, margin trends, ownership structure and peer set for Vivan Life Sciences Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 76/100, distress signals and MSME payment-delay disclosures - know whether Vivan Life Sciences Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Vivan Life Sciences Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Vivan Life Sciences Private Limited an active company?

Vivan Life Sciences Private Limited has MCA status “Active” with a compliance score of 88/100 (Low Risk).

Is Vivan Life Sciences Private Limited financially healthy?

Vivan Life Sciences Private Limited has a Financial Health Score of 50/100 (Moderate) based on its filed financial statements.

Should I do business with Vivan Life Sciences Private Limited?

Its overall Trust Score is 76/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Vivan Life Sciences Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Vivan Life Sciences Private Limited have loans or charges against its assets?

5 open charge(s) are registered against its assets, and 3 earlier charge(s) stand satisfied.

Is Vivan Life Sciences Private Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 88/100 (Low Risk).

Is it risky to lend to Vivan Life Sciences Private Limited?

Its Credit Risk Score is 80/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.